Global Measles, Mumps and Rubella (MMR) Vaccines Industry Research Report 2023, Forecast to 2030
- Report Code : WOR1840465
- Published On: Jul, 2020
- Category : Healthcare & Pharma
- Pages : 101
-
The Measles, Mumps and Rubella (MMR) Vaccines market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Measles, Mumps and Rubella (MMR) Vaccines is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Measles, Mumps and Rubella (MMR) Vaccines industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Measles, Mumps and Rubella (MMR) Vaccines by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Measles, Mumps and Rubella (MMR) Vaccines market are discussed.
The market is segmented by types:
Monovalent Vaccine
Polyvalent Vaccine
It can be also divided by applications:
Immune Center
Vaccine Development Agencies and Organizations
Hospital
Laboratory
Biotechnology and Biopharmaceutical Companies
And this report covers the historical situation, present status and the future prospects of the global Measles, Mumps and Rubella (MMR) Vaccines market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.
Finally, the report provides detailed profile and data information analysis of leading company.
Medlmmune
Emergent BioSolutions
Sanofi
Johnson & Johnson
Astellas Pharma
Merck
Pfizer
Bavarian Nordic
Serum
GlaxoSmithKline
CSL
Report Includes:
- xx data tables and xx additional tables
- An overview of global Measles, Mumps and Rubella (MMR) Vaccines market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Measles, Mumps and Rubella (MMR) Vaccines market
- Profiles of major players in the industry, including Medlmmune, Emergent BioSolutions, Sanofi, Johnson & Johnson, Astellas Pharma..
Research objectives
To study and analyze the global Measles, Mumps and Rubella (MMR) Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Measles, Mumps and Rubella (MMR) Vaccines market by identifying its various subsegments.
Focuses on the key global Measles, Mumps and Rubella (MMR) Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
To analyze the Measles, Mumps and Rubella (MMR) Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Measles, Mumps and Rubella (MMR) Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
-
With tables and figures helping analyze worldwide Global Measles Mumps and Rubella (MMR) Vaccines market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Measles, Mumps and Rubella (MMR) Vaccines Market Report 2020, Forecast to 2025
1 Scope of the Study1.1 Measles, Mumps and Rubella (MMR) Vaccines Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Measles, Mumps and Rubella (MMR) Vaccines Industry Overview2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Measles, Mumps and Rubella (MMR) Vaccines Global Import Market Analysis
2.1.2 Measles, Mumps and Rubella (MMR) Vaccines Global Export Market Analysis
2.1.3 Measles, Mumps and Rubella (MMR) Vaccines Global Main Region Market Analysis2.2 Market Analysis by Type
2.2.1 Monovalent Vaccine
2.2.2 Polyvalent Vaccine2.3 Market Analysis by Application
2.3.1 Immune Center
2.3.2 Vaccine Development Agencies and Organizations
2.3.3 Hospital
2.3.4 Laboratory
2.3.5 Biotechnology and Biopharmaceutical Companies2.4 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Measles, Mumps and Rubella (MMR) Vaccines Manufacturer Market Share
2.4.5 Top 10 Measles, Mumps and Rubella (MMR) Vaccines Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Measles, Mumps and Rubella (MMR) Vaccines Market
2.4.7 Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Offered
2.4.8 Mergers & Acquisitions Planning2.5 Measles, Mumps and Rubella (MMR) Vaccines Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Measles, Mumps and Rubella (MMR) Vaccines Industry Impact
2.7.1 How the Covid-19 is Affecting the Measles, Mumps and Rubella (MMR) Vaccines Industry
2.7.2 Measles, Mumps and Rubella (MMR) Vaccines Business Impact Assessment - Covid-19
2.7.3 Market Trends and Measles, Mumps and Rubella (MMR) Vaccines Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 Upstream and Downstream Market Analysis3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Cost Analysis3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Categorized by Regions (2015-2020)4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region
4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2015-2019)
4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Measles, Mumps and Rubella (MMR) Vaccines Market Size Detail
4.4.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020)
4.4.2 North America Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue, Price and Gross Margin (2015-2020)4.5 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size Detail
4.5.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020)
4.5.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue, Price and Gross Margin (2015-2020)4.6 Japan Measles, Mumps and Rubella (MMR) Vaccines Market Size Detail
4.6.1 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020)
4.6.2 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Measles, Mumps and Rubella (MMR) Vaccines Market Size Detail
4.7.1 China Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020)
4.7.2 China Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue, Price and Gross Margin (2015-2020)
5 Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment by Type5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, Sales and Market Share by Type (2015-2020)
5.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales and Market Share by Type (2015-2020)
5.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue and Market Share by Type (2015-2020)5.2 Monovalent Vaccine Sales Growth Rate and Price
5.2.1 Global Monovalent Vaccine Sales Growth Rate (2015-2020)
5.2.2 Global Monovalent Vaccine Price (2015-2020)5.3 Polyvalent Vaccine Sales Growth Rate and Price
5.3.1 Global Polyvalent Vaccine Sales Growth Rate (2015-2020)
5.3.2 Global Polyvalent Vaccine Price (2015-2020)
6 Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment by Application6.1 Global Measles, Mumps and Rubella (MMR) VaccinesSales Market Share by Application (2015-2020)
6.2 Immune Center Sales Growth Rate (2015-2020)
6.3 Vaccine Development Agencies and Organizations Sales Growth Rate (2015-2020)
6.4 Hospital Sales Growth Rate (2015-2020)
6.5 Laboratory Sales Growth Rate (2015-2020)
6.6 Biotechnology and Biopharmaceutical Companies Sales Growth Rate (2015-2020)
7 Global Measles, Mumps and Rubella (MMR) Vaccines Market Forecast7.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue Forecast
7.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Forecast (2020-2025)
7.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue and Growth Rate Forecast (2020-2025)
7.1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price and Trend Forecast (2020-2025)7.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Region (2020-2025)
7.2.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue Forecast (2020-2025)
7.2.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue Forecast (2020-2025)
7.2.3 Japan Measles, Mumps and Rubella (MMR) Vaccines Production, Revenue Forecast (2020-2025)
7.2.4 China Measles, Mumps and Rubella (MMR) Vaccines Production, Revenue Forecast (2020-2025)
8 Analysis of Measles, Mumps and Rubella (MMR) Vaccines Industry Key Manufacturers8.1 Medlmmune
8.1.1 Company Details
8.1.2 Product Information
8.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.1.4 Main Business Overview
8.1.5 Medlmmune News8.2 Emergent BioSolutions
8.2.1 Company Details
8.2.2 Product Information
8.2.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.2.4 Main Business Overview
8.2.5 Emergent BioSolutions News8.3 Sanofi
8.3.1 Company Details
8.3.2 Product Information
8.3.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.3.4 Main Business Overview
8.3.5 Sanofi News8.4 Johnson & Johnson
8.4.1 Company Details
8.4.2 Product Information
8.4.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.4.4 Main Business Overview
8.4.5 Johnson & Johnson News8.5 Astellas Pharma
8.5.1 Company Details
8.5.2 Product Information
8.5.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.5.4 Main Business Overview
8.5.5 Astellas Pharma News8.6 Merck
8.6.1 Company Details
8.6.2 Product Information
8.6.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.6.4 Main Business Overview
8.6.5 Merck News
8.7 Pfizer
8.7.1 Company Details
8.7.2 Product Information
8.7.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.7.4 Main Business Overview
8.7.5 Pfizer News
8.8 Bavarian Nordic
8.8.1 Company Details
8.8.2 Product Information
8.8.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.8.4 Main Business Overview
8.8.5 Bavarian Nordic News
8.9 Serum
8.9.1 Company Details
8.9.2 Product Information
8.9.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.9.4 Main Business Overview
8.9.5 Serum News8.10 GlaxoSmithKline
8.10.1 Company Details
8.10.2 Product Information
8.10.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.10.4 Main Business Overview
8.10.5 GlaxoSmithKline News
8.11 CSL
8.11.1 Company Details
8.11.2 Product Information
8.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.11.4 Main Business Overview
8.11.5 CSL News
9 Research Findings and Conclusion
10 Appendix
-
The Global Measles Mumps and Rubella (MMR) Vaccines Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
The Global Measles Mumps and Rubella (MMR) Vaccines study includes a diverse group of participants, including both market leaders and up-and-comers. Contact our sales representative to receive a complete list of companies covered in the study.
During the projected year from 2024 to 2029, the Global Measles Mumps and Rubella (MMR) Vaccines Market is expected to grow at a CAGR of xx%.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Global Measles Mumps and Rubella (MMR) Vaccines Market as well as its distribution among its players
The majority of data for the Global Measles Mumps and Rubella (MMR) Vaccines Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.
